控温链策略用于乙型肝炎病毒出生剂量疫苗在全球不同地区的成本效果:一项模型研究
该模型研究评估控温链(CTC)策略用于乙型肝炎病毒(HBV)出生剂量疫苗在六个世界区域和72个国家的成本效果。CTC策略在所有区域均产生健康收益,并在东亚和太平洋、拉丁美洲和加勒比、撒哈拉以南非洲、北非和中东区域具有成本节约。在HBV患病率高于平均水平、出生剂量覆盖率低于平均水平或出生剂量接种晚于平均水平的地区,节约更多且避免更多伤残调整生命年(DALY)。
要点
- CTC策略在所有区域均产生健康收益,并在四个区域具有成本节约。
- 中欧和东欧及中亚区域每避免一个DALY的成本为0.15美元(IQR -7.11至4.75)。
- 南亚区域每避免一个DALY的成本为79.72美元(66.47至94.47)。
核心结论
- 改善HBV出生剂量疫苗接种时机和覆盖率的CTC外展策略可能具有成本节约并减少围产期传播相关的HBV感染负担。
研究设计与样本
- 采用围产期HBV传播和疾病进展的数学模型,按HBV患病率、接种成本、出生剂量覆盖率和时机,在六个世界区域和72个国家中,每1000例出生计算与HBV相关的总DALY和成本,比较有无CTC策略。
主要发现
- CTC策略在所有区域均产生健康收益,并在东亚和太平洋、拉丁美洲和加勒比、撒哈拉以南非洲、北非和中东区域具有成本节约。
- 中欧和东欧及中亚区域每避免一个DALY的成本为0.15美元(IQR -7.11至4.75),南亚区域为79.72美元(66.47至94.47)。
- 在各国内部,HBV患病率高于平均水平、出生剂量覆盖率低于平均水平或出生剂量接种晚于平均水平的地区,节约更多且避免更多DALY。
关键数值与推荐
- 中欧和东欧及中亚区域每避免一个DALY的成本为0.15美元(IQR -7.11至4.75)。
- 南亚区域每避免一个DALY的成本为79.72美元(66.47至94.47)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The controlled temperature chain (CTC) strategy allows vaccines to be kept outside the cold chain for a short period of time. In remote rural areas, the CTC strategy for the hepatitis B virus (HBV) birth dose vaccination could improve its geographical coverage and timeliness of delivery, but with additional outreach costs. We assessed the cost-effectiveness of the CTC strategy for the HBV birth dose across six world regions and 72 countries according to their HBV prevalence, delivery costs, and birth dose coverage and timing. METHODS: By use of a mathematical model of perinatal HBV transmission and disease progression, we calculated per 1000 births the total HBV-related disability-adjusted life-years (DALYs) and costs, including vaccine delivery costs and costs associated with HBV-related disease, with and without the CTC strategy. FINDINGS: A CTC strategy produced health benefits in all regions and was cost-saving in the regions of east Asia and Pacific, Latin America and Caribbean, sub-Saharan Africa, and north Africa and Middle East. The CTC strategy cost US$0·15 (IQR -7·11 to 4·75) per DALY averted in the central and eastern Europe and central Asia region and $79·72 (66·47 to 94·47) in the south Asia region. Within individual countries, more savings were achieved and more DALYs averted in areas with above average HBV prevalence, below average birth dose coverage, or later than average birth dose delivery. INTERPRETATION: A CTC outreach strategy that improves the timing and coverage of the HBV birth dose vaccination is likely to be cost-saving and reduce the burden of HBV infection associated with perinatal transmission. FUNDING: Burnet Institute.
引用
- Scott N, Palmer A, Morgan C, et al. Cost-effectiveness of the controlled temperature chain for the hepatitis B virus birth dose vaccine in various global settings: a modelling study. Lancet Glob Health. 2018. PMID: 29773122. doi:10.1016/S2214-109X(18)30219-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。